Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17697209 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease
Condition: Celiac Disease
Interventions: Drug: larazotide acetate (AT-1001);   Drug: placebo

Indicates status has not been verified in more than two years